BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,236,000 | -24.4% | 2,874,602 | 0.0% | 3.14% | -8.6% |
| Q2 2019 | $10,895,000 | -58.8% | 2,874,602 | -11.5% | 3.44% | -55.6% |
| Q1 2019 | $26,448,000 | +0.9% | 3,249,164 | 0.0% | 7.74% | -31.2% |
| Q4 2018 | $26,221,000 | +5.8% | 3,249,164 | 0.0% | 11.26% | +70.0% |
| Q3 2018 | $24,791,000 | +75.6% | 3,249,164 | +31.9% | 6.62% | +56.6% |
| Q2 2018 | $14,120,000 | +33.3% | 2,464,241 | +11.0% | 4.23% | +65.4% |
| Q1 2018 | $10,594,000 | -13.1% | 2,220,971 | -10.5% | 2.56% | -12.5% |
| Q4 2017 | $12,187,000 | -26.5% | 2,482,119 | -21.6% | 2.92% | -36.3% |
| Q3 2017 | $16,587,000 | +20.5% | 3,165,457 | +27.9% | 4.58% | -16.6% |
| Q2 2017 | $13,762,000 | -73.0% | 2,475,167 | -59.2% | 5.50% | -73.7% |
| Q1 2017 | $50,998,000 | +32.7% | 6,071,142 | 0.0% | 20.86% | +13.2% |
| Q4 2016 | $38,430,000 | +52.3% | 6,071,142 | +6.1% | 18.43% | +42.3% |
| Q3 2016 | $25,230,000 | +55.3% | 5,721,142 | 0.0% | 12.95% | +32.1% |
| Q2 2016 | $16,248,000 | +22.4% | 5,721,142 | +22.0% | 9.81% | +12.3% |
| Q1 2016 | $13,271,000 | – | 4,689,435 | – | 8.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |